Amin Sepehr, Sepideh Fereshreh, Farzad Badmasti ©


کد: G-82435

نویسندگان: Amin Sepehr, Sepideh Fereshreh, Farzad Badmasti ©

زمان بندی: زمان بندی نشده!

برچسب: ویرایش شده

دانلود: دانلود پوستر

خلاصه مقاله: Abstract Objective: Nowadays, finding new antibiotics against A. baumannii seems necessary. Resistance to currently used antibiotics has limited effective drugs against this bacterium. Material and method: In this study, we targeted LpxA protein, which is involved in the early stage of LPS biosynthesis. In the next step, we used peptide 920 and 1,2- ETHANEDIOL as templates to find similar compounds using Drugbank and Zinc 15 web server, respectively. Finally, the characteristics, ADMET properties, water solubility and drug-likeness of the desired compounds were evaluated using SwissADME and DruLiTo software. Results: According to considered criteria, drug databases suggested 5 (Ilomastat, Macrolactam-1, Macrolactam-2, Macimorelin and Oglufanide) and 4 (ZINC895048, ZINC895081, ZINC901061 and ZINC1531008) compounds. The result of the HDOCK server and Molegro virtual docker (MVD) showed that Macrolactam-1 and ZINC895081 (Citrate) had the highest docking score. According to Lipinski's rule, these two compounds are non-carcinogenic, non-toxic and promising drugs against LpxA of A. baumannii. Conclusion: It seems that Macrolactam-1 and ZINC895081 (Citrate) are two valuable promising drugs against the LpxA protein of A. baumannii. Keywords: Acinetobacter baumannii, LpxA inhibitors, Virtual screening method, LPS biosynthesis, promising drugs, Macrolactam.

دیدگاه ها (0)

تاکنون دیدگاهی منتشر نشده است. شما اولین نفر باشید!

ارسال یک دیدگاه

ارسال دیدگاه توسط مدیریت بسته شده است.